Enanta Pharmaceuticals Stock Market Value
| ENTA Stock | USD 13.15 0.29 2.16% |
| Symbol | Enanta |
Enanta Pharmaceuticals Price To Book Ratio
Is Enanta Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (6.57) | Revenue Per Share 3.5 | Quarterly Revenue Growth (0.24) | Return On Assets (0.23) |
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Enanta Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enanta Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enanta Pharmaceuticals.
| 05/06/2022 |
| 04/25/2024 |
If you would invest 0.00 in Enanta Pharmaceuticals on May 6, 2022 and sell it all today you would earn a total of 0.00 from holding Enanta Pharmaceuticals or generate 0.0% return on investment in Enanta Pharmaceuticals over 720 days. Enanta Pharmaceuticals is related to or competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, and Inozyme PharmaInc. Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of ... More
Enanta Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enanta Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enanta Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.23 | |||
| Information Ratio | 0.0417 | |||
| Maximum Drawdown | 23.27 | |||
| Value At Risk | (4.89) | |||
| Potential Upside | 6.82 |
Enanta Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enanta Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enanta Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Enanta Pharmaceuticals historical prices to predict the future Enanta Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0493 | |||
| Jensen Alpha | 0.1633 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | 0.0475 | |||
| Treynor Ratio | 0.2655 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enanta Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enanta Pharmaceuticals Backtested Returns
We consider Enanta Pharmaceuticals not too volatile. Enanta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0417, which denotes the company had a 0.0417% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Enanta Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Enanta Pharmaceuticals' Downside Deviation of 3.23, semi deviation of 3.09, and Mean Deviation of 2.7 to check if the risk estimate we provide is consistent with the expected return of 0.16%. Enanta Pharmaceuticals has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.87, which means possible diversification benefits within a given portfolio. Enanta Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Enanta Pharmaceuticals is expected to follow. Enanta Pharmaceuticals right now shows a risk of 3.77%. Please confirm Enanta Pharmaceuticals sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to decide if Enanta Pharmaceuticals will be following its price patterns.
Auto-correlation | 0.04 |
Virtually no predictability
Enanta Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between Enanta Pharmaceuticals time series from 6th of May 2022 to 1st of May 2023 and 1st of May 2023 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enanta Pharmaceuticals price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Enanta Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.04 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 36.83 |
Enanta Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Enanta Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enanta Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Enanta Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Enanta Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Enanta Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enanta Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enanta Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enanta Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Enanta Pharmaceuticals Lagged Returns
When evaluating Enanta Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enanta Pharmaceuticals stock have on its future price. Enanta Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enanta Pharmaceuticals autocorrelation shows the relationship between Enanta Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Enanta Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Enanta Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enanta Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Enanta Stock
| 0.81 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.88 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
Moving against Enanta Stock
| 0.53 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Enanta Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enanta Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enanta Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enanta Pharmaceuticals to buy it.
The correlation of Enanta Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enanta Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enanta Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enanta Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Enanta Pharmaceuticals Correlation, Enanta Pharmaceuticals Volatility and Enanta Pharmaceuticals Alpha and Beta module to complement your research on Enanta Pharmaceuticals. For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Enanta Stock analysis
When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Enanta Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.